Beijing Leadman Biochemistry Co Ltd (300289) - Total Assets

Latest as of September 2025: CN¥1.81 Billion CNY ≈ $264.73 Million USD

Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) holds total assets worth CN¥1.81 Billion CNY (≈ $264.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 300289 net asset value for net asset value and shareholders' equity analysis.

Beijing Leadman Biochemistry Co Ltd - Total Assets Trend (2008–2024)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's total assets have evolved over time, based on quarterly financial data.

Beijing Leadman Biochemistry Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Beijing Leadman Biochemistry Co Ltd's total assets of CN¥1.81 Billion consist of 60.8% current assets and 39.3% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	31.5%
Accounts Receivable	CN¥113.71 Million	6.2%
Inventory	CN¥89.45 Million	4.9%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥25.17 Million	1.4%
Goodwill	CN¥73.53 Million	4.0%

Asset Composition Trend (2008–2024)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Beijing Leadman Biochemistry Co Ltd worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Beijing Leadman Biochemistry Co Ltd's current assets represent 60.8% of total assets in 2024, a decrease from 64.2% in 2008.
Cash Position: Cash and equivalents constituted 31.5% of total assets in 2024, up from 24.8% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 4.0% in 2008.
Asset Diversification: The largest asset category is accounts receivable at 6.2% of total assets.

Beijing Leadman Biochemistry Co Ltd Competitors by Total Assets

Key competitors of Beijing Leadman Biochemistry Co Ltd based on total assets are shown below.

Company	Country	Total Assets
INKON Life Technology Co Ltd SHE:300143	China	CN¥4.15 Billion
CareRay Digital Medical Technology Co Ltd SHG:688607	China	CN¥988.48 Million
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	USA	$139.92 Million
Universus Photo Imagings Limited NSE:UNIVPHOTO	India	Rs8.57 Billion
HansBiomed Corporation KQ:042520	Korea	₩126.41 Billion
Aligned Genetics Inc KQ:238120	Korea	₩45.11 Billion
Heramed Ltd AU:HMD	Australia	AU$1.04 Million
Acarix A/S ST:ACARIX	Sweden	Skr48.33 Million

Beijing Leadman Biochemistry Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	15.03	14.83	4.22
Quick Ratio	13.91	13.53	3.74
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.04 Billion	CN¥1.03 Billion	CN¥525.22 Million

Beijing Leadman Biochemistry Co Ltd - Advanced Valuation Insights

This section examines the relationship between Beijing Leadman Biochemistry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.31
Latest Market Cap to Assets Ratio	0.29
Asset Growth Rate (YoY)	-6.0%
Total Assets	CN¥1.82 Billion
Market Capitalization	$534.16 Million USD

Valuation Analysis

Below Book Valuation: The market values Beijing Leadman Biochemistry Co Ltd's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Beijing Leadman Biochemistry Co Ltd's assets decreased by 6.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Beijing Leadman Biochemistry Co Ltd (2008–2024)

The table below shows the annual total assets of Beijing Leadman Biochemistry Co Ltd from 2008 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥1.82 Billion ≈ $266.68 Million	-5.98%
2023-12-31	CN¥1.94 Billion ≈ $283.65 Million	-2.94%
2022-12-31	CN¥2.00 Billion ≈ $292.24 Million	-14.96%
2021-12-31	CN¥2.35 Billion ≈ $343.65 Million	+44.20%
2020-12-31	CN¥1.63 Billion ≈ $238.32 Million	-4.99%
2019-12-31	CN¥1.71 Billion ≈ $250.84 Million	-0.87%
2018-12-31	CN¥1.73 Billion ≈ $253.04 Million	-1.41%
2017-12-31	CN¥1.75 Billion ≈ $256.65 Million	+5.48%
2016-12-31	CN¥1.66 Billion ≈ $243.33 Million	+0.25%
2015-12-31	CN¥1.66 Billion ≈ $242.72 Million	+2.63%
2014-12-31	CN¥1.62 Billion ≈ $236.50 Million	+29.92%
2013-12-31	CN¥1.24 Billion ≈ $182.03 Million	+10.07%
2012-12-31	CN¥1.13 Billion ≈ $165.38 Million	+209.09%
2011-12-31	CN¥365.66 Million ≈ $53.51 Million	+41.34%
2010-12-31	CN¥258.71 Million ≈ $37.86 Million	+69.09%
2009-12-31	CN¥153.00 Million ≈ $22.39 Million	+34.32%
2008-12-31	CN¥113.91 Million ≈ $16.67 Million	--

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices

Market Cap

$534.16 Million

CN¥3.65 Billion CNY

Market Cap Rank

#12204 Global

#3768 in China

Share Price

CN¥6.71

Change (1 day)

-0.74%

52-Week Range

CN¥4.73 - CN¥11.33

All Time High

CN¥23.05